Psychedelics as potential mental health treatment are explored by Trump administration
The Trump administration has expressed interest in exploring psychedelics for their potential in treating PTSD and other debilitating mental health issues, various officials have shared.
"The Department shares the goal of ensuring that all Americans — especially our nation's veterans — have access to safe and effective treatments for conditions such as PTSD, addiction and depression," a spokesperson for the U.S. Department of Health and Human Services (HHS), run by Sec. Robert J. Kennedy Jr., said in a statement provided to Fox News Digital.
"Secretary Kennedy is committed to applying rigorous, evidence-based science to research efforts aimed at addressing these serious health challenges."
Fda Approves First Ai Tool To Predict Breast Cancer Risk
In recent years, researchers have been actively investigating the potential of psychedelics, such as MDMA and psilocybin ("magic mushrooms") to treat mental health disorders.
MDMA is not approved for clinical use by the U.S. Food and Drug Administration (FDA), but can be studied in clinical settings.
Read On The Fox News App
Psilocybin is listed as a Schedule I substance under the Controlled Substances Act, which means it has "a high potential for abuse, [is not] currently accepted for medical use in treatment in the United States, and [has] a lack of accepted safety for use under medical supervision."
Psilocybin-assisted therapy, however, is legal in Oregon, Colorado and New Mexico.
Psychedelic medicines are "showing real promise," according to Dr. Luke Twelves, general practitioner and vice president of medical for Lindus Health in London.
Clinical trials have found such treatments safe and effective for patients battling serious mental health issues, according to Twelves.
Common Supplements And Medications Could Cause Liver Damage, Studies Show
"Take psilocybin, for example — it's demonstrating remarkable results for severe depression that hasn't responded to other medications," he told Fox News Digital. "MDMA is showing similar breakthroughs for PTSD treatment."
Clinical trials are also investigating how psychedelics could help with end-of-life anxiety, addiction, eating disorders, chronic pain and OCD, he added.
Researchers have faced challenges in terms of regulatory hurdles and proper placebo controls, Twelves said.
"Given that these treatments could transform [the] lives of people suffering from conditions where nothing else has worked effectively, it's crucial that we complete this research properly," he said. "The goal is to bring safe, proven psychedelic therapies to the patients who need them most."
At President Trump's May 1 cabinet meeting, Department of Veterans Affairs Secretary Doug Collins said that "we're opening up the possibility of psychedelic treatment."
Retired Army Sergeant Jonathan Lubecki recently told Fox News' Alexandria Hoff that MDMA stopped his PTSD while he was participating in a clinical trial.
"[I] took my first dose of MDMA. I've only taken it three times as part of the clinical trial, haven't taken it since, and haven't found the need to take it since, because I haven't had PTSD," he said.
Peter Kasperowicz, Department of Veterans Affairs press secretary, told Fox News Digital the department is safely exploring all avenues that promote the health of veterans.
Fallujah Vet Turns Medal Of Heroism Into A Healing Mission For Fellow Warriors With Service Dogs Program
"Preliminary findings have produced positive results on psychedelic-assisted therapies for treating mental health conditions," he said.
The VA is currently running 11 clinical trials in various phases, with a total of some 800 veterans expected to participate.
"The goal of these trials is to determine whether compounds such as MDMA and psilocybin can treat veterans with post-traumatic stress disorder, treatment-resistant depressive disorder, major depressive disorder and potentially other mental health conditions," said Kasperowicz.
An MDMA study published in the Jan. 2025 issue of The American Journal of Psychiatry found that the substance is "unlike classical psychedelics."
The study noted, "MDMA allows the individual to maintain intact ego functioning and a greater degree of cognitive and perceptual lucidity while still experiencing a prosocial altered state of consciousness that facilitates deeply emotional therapeutic breakthroughs."
Click Here To Sign Up For Our Health Newsletter
The researchers concluded that MDMA showed "enhanced levels of trust, empathy, self-compassion and a 'window of tolerance'" that traditional psychotherapy lacks.
Doug Drysdale, CEO of the Canadian pharmaceutical company Cybin, told Fox News Digital that "the time is now to address the mental health crisis."
He said it is "gratifying" that administration officials value the potential benefits of looking into alternative mental health treatments.
Cybin is currently in phase 3 of a study of CYB003, a type of psilocybin that has been granted breakthrough therapy designation by the FDA as an additional treatment for major depressive disorder (MDD).
"In Cybin's completed Phase 2 MDD study, long-term efficacy results showed that 71% of participants were in remission from depression, and 100% of participants responded to treatment at 12 months after just two 16 mg doses of CYB003," said Drysdale.
Dr. Marc Siegel, clinical professor of medicine at NYU Langone Medical Center and Fox News' senior medical analyst, previously interviewed two of the country's top researchers on psychedelics — Dr. Rachel Yehuda, founder and director of the Center for Psychedelic Psychotherapy and Trauma Research at Mt. Sinai in New York, and Dr. Charles Marmar, director of the PTSD research program at NYU Langone.
"They agree there is therapeutic potential if very carefully studied under very strict medical guidance, but there is a huge downside in terms of unregulated recreational uses," Siegel told Fox News Digital at the time.
"Both doctors see likely therapeutic value to psychedelics if carefully managed by medical experts," Siegel added.
Ryan Moss, chief science officer at Filament Health, a clinical-stage natural psychedelic drug development company in Canada, emphasized it's important to administer psychedelics in a safe setting when treating mental health conditions.
For more Health articles, visit www.foxnews.com/health
"Psychedelic experiences can sometimes feature anxiety, hallucinations and paranoia," Moss previously told Fox News Digital. "Some patients using traditional psychedelics have reported experiencing adverse cardiovascular events during clinical trials."
To mitigate these risks, Moss recommended clinical trial participants receive thorough preparation and monitoring by trained professionals during sessions.
Melissa Rudy and Angelica Stabile, both of Fox News Digital, contributed reporting.Original article source: Psychedelics as potential mental health treatment are explored by Trump administration
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles

Epoch Times
an hour ago
- Epoch Times
Why Drug Price Reform Alone Won't Heal America
President Donald Trump's revived effort to reduce prescription drug prices is a long-overdue step toward affordability. For millions of Americans, the cost of staying alive has become burdensome, and any policy that eases the burden is worth celebrating. However, as a physician, I've seen what happens when medications become too cheap, plentiful, and automatic. If we don't reform how drugs are used, we risk trading financial hardship for clinical harm. Vagaries of Lower Drug Costs In today's health care system, medication is the first answer—and often the last, especially for older adults. More than 40
Yahoo
4 hours ago
- Yahoo
Measles resurgence highlights the toll of RFK Jr.'s anti-vaccine policies
After the U.S. surpassed 1,000 reported measles cases nationwide, it's clear the Trump administration is failing to protect our health and well-being. The measles outbreak in Texas is now the largest since 2000, when the country eliminated measles. And it's not yet over, threatening to make measles endemic in America again, where the risk of infection comes from within our country. Furthermore, two unvaccinated school-aged children in Texas died from measles, the first American children to die from the viral infection since 2003. Normally, a preventable infection causing avoidable deaths of children would lead to prompt government action. In 1991, I was a medical student with the U.S. Public Health Service in Philadelphia during a large measles outbreak. Over 1,000 people were infected, and nine children died. Government and public health leaders required home visits of infected children, mass immunization, education efforts and even court-mandated vaccinations. The outbreak was stopped. In Dec. 2014, a measles outbreak began at Disneyland and spread in communities with low vaccination rates. Public health action stopped this large outbreak at 125 cases. To prevent further outbreaks in California, I authored Senate Bill 277, which eliminated non-medical exemptions for school vaccines. And with further U.S. measles outbreaks in 2019, I authored Senate Bill 276 to crack down on fraudulent medical exemptions. These laws — championed by California parents demanding safe schools for children — raised statewide vaccination rates and shielded our communities. As Congress waits, Health and Human Services Secretary Robert F. Kennedy Jr. is dismantling decades of public health achievement that will make America sicker. Kennedy reduced vaccine outreach, removed key public health officials, spread disinformation from his official post and suppressed data while elevating conspiracy theorists to top positions. Kennedy and the Department of Government Efficiency fired a quarter of Health and Human Services staff, gutting the Centers for Disease Control and Prevention (CDC) and National Institutes of Health teams vital to outbreak response. He installed anti-vaccine extremists as advisors, including David Grier, a discredited researcher disciplined for unethical experiments on children with autism, to 'research' if vaccines cause autism, despite decades of research debunking this myth. The CDC has been muzzled: An analysis showing high rates of measles in low vaccination areas was suppressed, and dozens of Texas vaccination clinics were forced to close. When Kennedy dismantled the CDC's communication team, his former anti-vaccine organization, Children's Health Defense, filled the void with disinformation by publishing a fake CDC-branded vaccine 'safety' website that falsely linked vaccines to autism. The site mimicked official CDC design and branding, deliberately misleading the public. After news reports exposed the deception and forced the site's removal, no federal action has been taken to investigate or prosecute this unlawful impersonation of a federal agency. Furthermore, Dr. Peter Marks, the nation's top vaccine regulator who led President Donald Trump's Operation Warp Speed, refused a demand for false data on brain swelling and death caused by the Measles-Mumps-Rubella vaccine, of which there are no credible cases. Kennedy forced him to resign. In his resignation letter, Marks wrote, 'it has become clear that truth and transparency are not desired by the secretary, but rather he wishes subservient confirmation of his misinformation and lies.' And what of the dead children from measles? Kennedy dismissed the first measles death, saying 'it's not unusual.' He blamed measles on poor nutrition, called vaccines a 'personal choice' that could cause 'adverse events' and claimed Vitamin A and cod liver oil treated measles. Subsequently, many Texas children hospitalized with measles also had Vitamin A toxicity. At his first Congressional hearing, Kennedy testified, 'I don't think people should be taking medical advice from me.' He then refused to answer whether he would vaccinate a child against polio. As Health and Human Services secretary, he cravenly refuses to save Americans in a public health crisis. How many children must get sick — and even die — before Congress demands that Kennedy and the Trump administration answer for these preventable deaths and the continued spread of a preventable disease? This flu season, as flu vaccination declined, 226 children died from influenza — the highest since the 2009-10 pandemic. Other preventable and deadly diseases, including polio and whooping cough, will also return when vaccination is hampered and discouraged. Our state has made progress in raising vaccination rates, but we are not immune to Kennedy's dangerous vaccine disinformation; California has communities with enough unvaccinated people to fuel a serious outbreak. Measles outbreaks in other states makes it imperative that California strengthen our public health defenses against sparks of infection. And California needs Congress to hold President Donald Trump and Kennedy accountable for not stopping preventable disease in America. Dr. Richard Pan is a pediatrician and former California state senator who authored landmark legislation to eliminate non-medical exemptions to school vaccination requirements in response to major measles outbreaks.


The Hill
4 hours ago
- The Hill
Trump stokes fear, confusion with pulled emergency abortion guidance
The Trump administration sowed confusion and fear among physicians with its move this past week to rescind Biden-era guidelines to hospitals that provide life-saving abortions. While the move doesn't change the law, doctors and reproductive-rights advocates fear it will have a chilling effect on health care workers in states with abortion bans, ultimately harming pregnant women. Earlier this past week, the Department of Health and Human Services (HHS) and the Centers for Medicare and Medicaid Services (CMS) announced they would rescind guidance issued during the Biden administration, which reinforced to hospitals that under the Emergency Medical Treatment and Labor Act (EMTALA,) abortions qualify as stabilizing care in medical emergencies. Emergency rooms in states with abortion bans have been struggling since the 2022 overturning of Roe v. Wade to understand when they can legally provide emergency abortions. After President Trump pulled the Biden-era guidance seeking to clarify that question, emergency room doctors will experience 'more confusion' and 'more fear,' according to health and legal experts who spoke with The Hill. 'Clinicians are scared to provide basic medical care, and this care is clearly in line with medical ethics … medical standards of care, and they're being put in this situation where they can't win,' said Payal Shah, director of research, legal and advocacy at Physicians for Human Rights. Since the Supreme Court overturned Roe v. Wade in 2022, at least 13 states have enacted near-total abortion bans, according to data from the Guttmacher Institute. There are exceptions in these states when continuing a pregnancy poses a threat to the health or life of the mother. However, most of the language in state laws is unclear on how that determination is made, resulting in instances of emergency rooms denying care. Doctors in states like Idaho, Texas and Tennessee have filed lawsuits requesting that lawmakers clarify when an abortion is allowed to save the life of a pregnant person. The doctors and patients involved in the lawsuits argue that state laws do not adequately protect pregnant patients in emergencies. Many of these states have severe punishments for doctors who violate abortion bans, like steep fines and prison time. 'For clinicians, there is actually no safe way to navigate this in this moment, and ultimately, that's how these laws are designed,' Shah said. 'They're designed to cause chaos and confusion. They're often written in ways that don't use medical terminology.' Without clear guidance, pregnant women suffer and sometimes die, as ProPublica has reported. One striking example of this is the 2023 case of Kyleigh Thurman, a Texas woman who was repeatedly denied care for a nonviable pregnancy after days of experiencing bleeding and pain. Health care workers discovered that she had an ectopic pregnancy, which is when a fertilized egg implants and begins to grow outside of the uterus, usually in a fallopian tube. Ectopic pregnancies are never viable and are life-threatening if not treated properly. It wasn't until her OB/GYN 'pleaded to hospital staff that she be given care,' that the hospital administered a shot ending her pregnancy, according to a complaint filed by the Center for Reproductive Rights on behalf of Thurman. The shot came too late, and the ectopic pregnancy ruptured Thurman's right fallopian tube, which was then removed. 'If a patient is actively hemorrhaging or experiencing an ectopic pregnancy which is also life-threatening, doctors need that clear guidance that yes, EMTALA applied,' said Autumn Katz, associate director of U.S. litigation at the Center for Reproductive Rights. A federal investigation into Thurman's case found that the Texas hospital violated EMTALA, according to a recent letter from the CMS. 'I finally got some justice,' Thurman said in a statement. 'I hope this decision will do some good in encouraging hospitals to help women in situations like mine.' Hospitals that violate EMTALA are subject to heavy fines and, in some extreme cases, risk losing a portion of their Medicare and Medicaid hospital funding, according to the National Institutes of Health. Former President Biden leaned on the law to preserve access to emergency abortion across the country, leading to a legal fight with Idaho, which has a strict abortion ban. The Supreme Court last year dismissed the case, declining to rule on the merits of a politically charged case. The rescinding of these guidelines also means hospitals that violate the law will likely not be investigated as often as they were under previous administrations, according to Shah. That lack of punitive risk means that hospitals could be incentivized to deny life-saving care for patients. 'The standard of EMTALA is pretty high,' said Katherine Hempstead, senior policy adviser at Robert Wood Johnson Foundation. 'This kind of takes that layer of reassurance away, and it will make a lot of providers feel very vulnerable.'